Showing results (211-220 of 415) with videos related to

Sort By:
Pageof 42
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|January 12, 2026
Community-onset symptomatic urinary tract infections (SUTI) caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales: independent predictors and comparative effectiveness of oral agentsShani Zilberman-Itskovich, Majdi Masarwi, Eyal Levy, et al.
Pharmacotherapy|February 3, 2019
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)Brian T Tsuji, Jason M Pogue, Alexandre P Zavascki, et al.
Infection Control and Hospital Epidemiology|October 7, 2009
Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin tossCarrie A Herzke, Luke F Chen, Deverick J Anderson, et al.
Future Microbiology|February 26, 2025
Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant EnterobacteralesTanaya Bhowmick, Rafael Canton, Federico Pea, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniaeDeverick J Anderson, John J Engemann, Lizzie J Harrell, et al.
Infectious Diseases and Therapy|August 20, 2014
Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin ActivityMolly E Steed, Ashley D Hall, Hossein Salimnia, et al.
Pharmacotherapy|January 12, 2013
Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremiaRavina Kullar, Susan L Davis, Keith S Kaye, et al.
Infectious Disease Clinics of North America|August 7, 2021
Antimicrobial Stewardship and the Infection Control Practitioner: A Natural AllianceShiwei Zhou, Jerod L Nagel, Keith S Kaye, et al.
International Journal of STD & AIDS|December 13, 2007
A comparison of the effectiveness of lipid-lowering therapy between HIV- and non-HIV-infected subjects with hyperlipidaemiaMary L Townsend, Stephanie B Hollowell, Jasmin Bhalodia, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosaKeith S Kaye, Zeina A Kanafani, Ashley E Dodds, et al.
Pageof 42